Siegfried Reich, P.H.D
2020
In 2020, Siegfried Reich, P.H.D earned a total compensation of $5.7M as Executive Vice President and Chief Scientific Officer at Turning Point Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $187,097 |
|---|---|
| Option Awards | $5,227,485 |
| Salary | $325,000 |
| Total | $5,739,582 |
PHD received $5.2M in option awards, accounting for 91% of the total pay in 2020.
PHD also received $187.1K in non-equity incentive plan and $325K in salary.
Rankings
In 2020, Siegfried Reich, P.H.D's compensation ranked 1,858th out of 13,090 executives tracked by ExecPay. In other words, PHD earned more than 85.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,858 out of 13,090 | 86th |
Division Manufacturing | 721 out of 5,621 | 87th |
Major group Chemicals And Allied Products | 261 out of 2,254 | 88th |
Industry group Drugs | 219 out of 1,954 | 89th |
Industry Pharmaceutical Preparations | 156 out of 1,459 | 89th |
Source: SEC filing on April 29, 2022.
PHD's colleagues
We found four more compensation records of executives who worked with Siegfried Reich, P.H.D at Turning Point Therapeutics in 2020.